Beyond First Line: Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis

Expert faculty discuss the pharmacist’s role in the treatment of myelofibrosis with an on-demand webcast of a live symposium, downloadable slides, and commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

Supported by an educational grant from GSK.

GSK

Partners

Clinical Care Options, LLC

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

 In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)

Additional Information

In coordination with HOPA's Annual Conference